Searchable abstracts of presentations at key conferences in endocrinology

ea0016p650 | Reproduction | ECE2008

Reactive nitrogen species in the chemical biology of sperm functions

Vignini Arianna , Bildreghini Eddi , Nanetti Laura , Raffaelli Francesca , Paggi Francesca , Mazzanti Laura , Mantero Franco , Boscaro Marco , Balercia Giancarlo

Inflammation activates a variety of inflammatory cells, which induce and activate several oxidant-generating enzymes which are able to produce high concentrations of free radicals and oxidants which react with each other to generate other more potent reactive oxygen and nitrogen species such as peroxynitrite (ONOO−) that can damage DNA, RNA, lipids, and proteins by nitration, oxidation, etc., leading to increased mutations and altered functions of enzymes and ...

ea0063p646 | Interdisciplinary Endocrinology 1 | ECE2019

Spingosine-1-phosphate induces cAMP/PKA-independent pCREB activation, but not steroidogenesis, in human granulosa cells

Paradiso Elia , Lazzaretti Clara , Riccetti Laura , Sperduti Samantha , Antoniani Francesco , Brigante Giulia , Feo Gaetano De , Morini Daria , Iannotti Francesca , Simoni Manuela , Poti Francesco , Casarini Livio

Sphingosine-1 phosphate (S1P) is a lysosphingolipid present in the ovarian follicular fluid at the nanomolar concentration. The physiological functions of S1P are mediated through five specific G protein-coupled receptors (GPCRs), known as S1PR1-5. S1PR1 and S1PR3 are expressed in human primary granulosa lutein cells (hGLC), as well as in the immortalized human primary granulosa cell line hGL5. S1PRs are activated at nanomolar concentrations inducing specific activation or inh...

ea0031s10.3 | Lipodystrophy – The perils of being thin | SFEBES2013

HIV lipodystrophy

Villarroya Francesc , Domingo Pere , Giralt Marta

HIV-1-infected patients under antirretroviral treatment develop the so-called ‘lipodystrophy syndrome’. It is characterized by peripheral lipoatrophy (face, limbs), visceral lipohypertrophy, and, sometimes abnormal accumulation of subcutaneous fat in specific sites, especially the dorso-cervical area. The abnormal fat distribution is associated with systemic alterations characteristic of the metabolic syndrome (dyslipidemia, insulin resistance). Drugs are importantly...

ea0063p644 | Interdisciplinary Endocrinology 1 | ECE2019

Dominance of ovarian follicles is determined by follicle-stimulating hormone receptor (FSHR) and G protein-coupled estrogen receptor (GPER) heteromers

Casarini Livio , Lazzaretti Clara , Paradiso Elia , Riccetti Laura , Sperduti Samantha , Marcozzi Serena , Sayers Niamh , Brigante Giulia , Poti Francesco , La Marca Antonio , Valli Barbara , Falbo Angela , Villani Maria Teresa , Klinger Francesca Gioia , Fane Francesca , Hanyaloglu Aylin Carla , Simoni Manuela

Mechanisms regulating the selection of antral ovarian follicles are poorly understood and supposed to rely on low estrogen levels, decline of follicle-stimulating hormone (FSH) levels and receptor (FSHR) expression on the surface of granulosa cells. These concepts are challenged in-vitro, where apoptosis of human granulosa cells (hGLC) and transfected cell lines is induced by high doses of FSH or FSHR overexpression, while estrogens induce anti-apoptotic signals via n...

ea0037s20.3 | Endocrine consequences of childhood cancer treatment | ECE2015

Late effects of cancer treatment on cardiovascular risk

Felicetti Francesco

In the last 50 years survival after childhood cancer has dramatically improved. However, childhood cancer survivors (CCS) are at risk for a considerable array of late effects arising from previous anti-cancer therapies. The excess mortality (compared with the general population) in CCS is mostly due to second neoplasms and cardiovascular diseases. Indeed, the cardiovascular system has been recognized as a highly sensitive target for damage by anti-cancer therapies. Early in th...

ea0015s48 | PCOS: impact on long-term health outcomes | SFEBES2008

Cardiovascular implications of polycystic ovary syndrome

Orio Francesco

The polycystic ovary syndrome (PCOS) is actually considered not only a reproductive disease but also a multifaceted disease with metabolic, cardiovascular and long-term health implications, including diabetes mellitus and coronary artery disease. In particular, insulin resistance, hyperandrogenemia and dyslipidemia are likely the major risk factors for the occurrence of cardiovascular disease (CVD) in PCOS. These cardiovascular risk (CVR) factors are often evident at an early ...

ea0081oc3.5 | Oral Communications 3: Thyroid 1 | ECE2022

Functional analysis of exosomal miRNAs secreted by thyroid cancer cells

Verrienti Antonella , Maggisano Valentina , Capriglione Fancesca , Sponziello Marialuisa , Pecce Valeria , Durante Cosimo , Celano Marilena , Bulotta Stefania , Russo Diego

Background: MiRNAs transported by exosomes play a role in various processes of tumorigenesis and tumor progression. They can function as oncogenes able to structurally and biologically change the tumor microenvironment (TME) therefore playing a crucial role in cell-to-cell communication during tumor development and allowing cancer cells to become invasive and disseminate from the primary site to distant locations.We aimed to identify the exosome miRNAs that may be involved in ...

ea0063p256 | Pituitary and Neuroendocrinology 1 | ECE2019

Hyperglycemia and pasireotide lar in acromegaly: a study with continuous glucose monitoring

Russo Lucia , Mazzocut Sara , Dassie Francesca , Parolin Matteo , Martini Chiara , Carlo Eugenio De , Fallo Francesco , Mioni Roberto , Vettor Roberto , Maran Alberto , Maffei Pietro

Background: Pasireotide LAR is a multireceptor targeted somatostatin analogue that has been shown to obtain a better biochemical control of acromegaly. However, pasireotide LAR could induce hyperglycemia in acromegalic patients with higher baseline glucose values. The devices that can track interstitial glucose levels such as continuous glucose monitoring (CGM) could be a useful for studying the impact of SSA on patients’ glucose status.Aim: We aime...

ea0063p645 | Interdisciplinary Endocrinology 1 | ECE2019

Demonstration of follicle-stimulating hormone receptor (FSHR) and G protein-coupled estrogen receptor (GPER) heterodimerization by bioluminescence resonance energy transfer (BRET)

Lazzaretti Clara , Paradiso Elia , Riccetti Laura , Sperduti Samantha , Brigante Giulia , Poti Francesco , Fanelli Francesca , Simoni Manuela , Hanyaloglu Aylin Carla , Casarini Livio

During the menstrual cycle, selection of the dominant follicle is characterized by changes of gonadotropin and steroid hormone receptor expression. We aim to evaluate whether co-existing follicle-stimulating hormone receptor (FSHR) and G protein-coupled estrogen receptor (GPER) form heterodimers, suggesting their role in ovarian follicle selection. FSHR-GPER dimerization was evaluated in transfected HEK293 cells in vitro by bioluminescence resonance energy transfer (B...

ea0063p1101 | Pituitary and Neuroendocrinology 3 | ECE2019

Pegvisomant: daily versus non daily administration a single centre real life study

Dassie Francesca , Rosson Marco , Parolin Matteo , Russo Lucia , Mazzocut Sara , Martini Chiara , De Carlo Eugenio , Mioni Roberto , Fallo Francesco , Vettor Roberto , Maffei Pietro

Background: Pegvisomant (PEG) is a second line medical treatment for active acromegalic patients. PEG efficacy is between 61.5 and 92% and even if it is administered daily its long half-life suggests a possible use with a non-daily regime.Aim: We aim to compare acromegalic patients on daily PEG administration (DP) with patients on non-daily PEG administration (NDP).Methods: We studied 43 acromegalic patients under PEG treatment bet...